AstraZeneca’s Farxiga reduces risk of severe heart failure or related death in DELIVER Phase III trial
According to the data, Farxiga continues to provide clinically significant advantages to patients with heart failure regardless of…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
29 Aug 22
According to the data, Farxiga continues to provide clinically significant advantages to patients with heart failure regardless of…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
26 Aug 22
The approval was given by the Japanese Ministry of Health, Labour, and Welfare after assessing the findings of…
26 Aug 22
With the planned spin-off, Sandoz will become a large-scale, independent company focused on biosimilars, antibiotics and generic medicines,…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
25 Aug 22
Imbruvica is a once-daily oral medication, jointly developed by Janssen and AbbVie’s subsidiary Pharmacyclics, that works by blocking…
25 Aug 22
The global weight loss supplements market share is expected to grow from $30.12 billion in 2021 to $34.19 billion in 2022 at…
25 Aug 22
The new flavors join original Freshie Lime flavor and come in four-packs and a new eight-can variety pack,…
25 Aug 22
Energy efficient appliances? Rebate. Eco-friendly car? Rebate. Now, choosing sustainable bacon earns its own rewards. Claiming the Bacon…
NutraceuticalsProtein and Peptide Synthesis and Manufacturing
25 Aug 22
These physical collectible boxes have been created for fans of both KINGSHIP and M&M'S and are only available…
25 Aug 22
The new facility in Plainville, Massachusetts is intended to manufacture materials central to the production of gene-based therapeutics
24 Aug 22
In the updated analysis, the Pfizer-BioNTech Covid-19 vaccine showed 73.2% efficacy in children aged six months to four…